Endocrine Targets: Treating Steatotic Liver Disease

Endocrine dysfunction plays a prominent role in the development of steatotic liver disease and was featured prominently with a multi-session program at ENDO 2023. Endocrinologists will be on the front lines to help patients stave off this disorder that will no longer be known as “fatty liver disease,” which is projected to become the leading […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:


Share this article